Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10087932 | 0.94 | LMNA (0.52) | ALDH1A1LMNAATMTSHRHCAR2 | |
| SCHEMBL6897000 | 0.92 | LMNA (0.55) | ALDH1A1LMNATSHRHCAR2NAAA | |
| SCHEMBL27482658 | 0.90 | ALDH1A1 (0.47) | ALDH1A1LMNAATMTSHRHPGD | |
| SCHEMBL28887013 | 0.90 | ALDH1A1 (0.47) | ALDH1A1LMNAATMTSHRHPGD | |
| SCHEMBL11877269 | 0.90 | ALDH1A1 (0.47) | ALDH1A1LMNAATMTSHRHPGD | |
| SCHEMBL14715673 | 0.89 | TSHR (0.42) | ALDH1A1LMNAATMTSHRHPGD | |
| SCHEMBL14891234 | 0.87 | ALDH1A1 (0.52) | ALDH1A1LMNAATMTSHRHPGD | |
| SCHEMBL577735 | 0.86 | LMNA (0.42) | ALDH1A1LMNATSHRHCAR2TDP1 | |
| SCHEMBL7665438 | 0.86 | ALDH1A1 (0.40) | ALDH1A1LMNAATMTSHRHPGD | |
| SCHEMBL6008417 | 0.85 | ALDH1A1 (0.50) | ALDH1A1LMNAATMTSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5412003-A | Filled with hollow glass microspheres with reduced alkalinity to improve water resistance, automobile panels | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-02 | — | — | US | claimed |
| WO-2025119860-A1 | LIQUID AGROCHEMICAL FORMULATIONS COMPRISING FLUPYRADIFURONE | BAYER AKTIENGESELLSCHAFT (DE) | 2025-06-12 | — | — | WO | disclosed |
| EP-3771014-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR POWER STORAGE DEVICES | TOMIYAMA PURE CHEMICAL INDUSTRIES LTD (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-12155037-B2 | Nonaqueous electrolyte solution for power storage devices | TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2024-11-26 | — | — | US | disclosed |
| US-12107226-B2 | Electrolyte for power storage devices and nonaqueous electrolyte solution | TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2024-10-01 | — | — | US | disclosed |
| US-20240131180-A1 | DRUG ANTIBODY CONJUGATES | PHARMA MAR, S.A. (ES) | 2024-04-25 | — | — | US | disclosed |
| EP-4025253-B1 | DRUG ANTIBODY CONJUGATES | PHARMA MAR SA (ES) | 2024-03-20 | — | — | EP | disclosed |
| US-20240088444-A1 | ELECTROLYTE FOR POWER STORAGE DEVICES AND NONAQUEOUS ELECTROLYTE SOLUTION | TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2024-03-14 | — | — | US | disclosed |
| CN-114615999-B | Drug antibody conjugates | 法马马有限公司 | 2024-03-08 | — | — | CN | disclosed |
| EP-4318629-A1 | PRIMER FOR POWER STORAGE DEVICE ELECTRODES, COMPOSITION FOR FORMING PRIMER LAYER, ELECTRODE FOR POWER STORAGE DEVICES, AND SECONDARY BATTERY | AGC INC. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-5412003-A | Filled with hollow glass microspheres with reduced alkalinity to improve water resistance, automobile panels | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-02 | — | — | US | disclosed |
| US-5395865-A | Storage stable compositions containing a polymerization inhibitor | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-03-07 | — | — | US | disclosed |
| EP-0628559-A1 | Pyrimidine compounds and their use as pharmaceuticals | Beiersdorf-Lilly GmbH (DE) | 1994-12-14 | — | — | EP | disclosed |
| EP-0603001-A1 | Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease | SANKYO COMPANY LIMITED (JP) | 1994-06-22 | — | — | EP | disclosed |
| EP-0573218-A2 | 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use | SANKYO COMPANY LIMITED (JP) | 1993-12-08 | — | — | EP | disclosed |
| EP-0567271-A2 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO COMPANY LIMITED (JP) | 1993-10-27 | — | — | EP | disclosed |
| EP-0552789-A1 | Unsaturated polyester resin compositions, molding materials, and molded products | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| EP-0545912-A2 | 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1993-06-09 | — | — | EP | disclosed |
| EP-0542494-A1 | Unsaturated polyester compositions, molding materials and molded products | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-05-19 | — | — | EP | disclosed |
| EP-0503785-A1 | 1-Biphenylimidazole derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1992-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131180-A1 | DRUG ANTIBODY CONJUGATES | STT3B, STT3A, TTL | ALDH1A1 785/4885LMNA 1254/4885ATM 3058/4885 |
| US-12155037-B2 | Nonaqueous electrolyte solution for power storage devices | AQP1, NCS1, SLC9A1 | ALDH1A1 1681/4885LMNA 2823/4885ATM 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.